NEU 0.85% $15.14 neuren pharmaceuticals limited

Share Price, page-11435

  1. 1 Posts.
    lightbulb Created with Sketch. 10
    Wiji, seems I might have been the only one there as no one has replied.

    First time posting - long time reader. Been in Neuren since FY15 @ 10 cents (pre-consolidation obviously).
    Recently purchased hard again at $17 and $15 as my risk return against other options on the market, keeps pushing Neuren to the top of the list.

    I'm aware of confirmation bias, but anyway I cut it or stress test it, I feel we are still extremely good value, considering how de-risked we now are.

    Decided to make the long trip to Melbourne from NW NSW for this event and left extremely confident of my investments.

    John presented very similar to everything I have seen online previously - no new information - but I got a real comfortable, confident feeling from him.
    Watching his presentation with the other CEO's yesterday (some others were also very impressive) also strengthened my confidence in that we have the right person in charge of our future.

    The main point you're probably looking for was it was pretty clear to me, unless someone is prepared to pay up for Neuren, we are going to push NNZ-2591 all the way with our current funds and future earnings available - no planned extra capital raises just organic growth from here. He confirmed again that all of their resources are now directed to NNZ-2591 as Acadia have full control with Daybue (our only involvement is getting paid regularly from them)

    I'm in till the end.

 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.